Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1Anemia, Refractory, with Excess of Blasts 1Anemia, Aplastic 1

Interventions

Cyclophosphamide 102fludarabine phosphate 94Mycophenolic Acid 81Tacrolimus 70Whole-Body Irradiation 65Peripheral Blood Stem Cell Transplantation 65fludarabine 49Busulfan 49Cyclosporine 48Antilymphocyte Serum 44Melphalan 39Filgrastim 37Methotrexate 32Radiotherapy 25Granulocyte Colony-Stimulating Factor 22Cord Blood Stem Cell Transplantation 20Sirolimus 19Rituximab 19thymoglobulin 18Stem Cell Transplantation 18Methylprednisolone 16Alemtuzumab 16Thiotepa 13sargramostim 11Cytarabine 11Cyclosporins 11Clofarabine 11Therapeutics 10Flow Cytometry 10Etoposide 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hodgkin Disease × Parathyroid Hormone × Myeloid × Clear all
NCT00393380 2013-04-29

Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor

The Emmes Company, LLC

Phase 2 Terminated
13 enrolled 14 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Aplastic, Anemia, Refractory, with Excess of Blasts, Hodgkin Disease, Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡